Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen

Changhoon YOO; Bum-Jun KIM; Kyu-pyo KIM; Jae-Lyun LEE; Tae-Won KIM; Baek-Yeol RYOO; Heung-Moon CHANG.
Cancer Research and Treatment ; : 759-765, 2017.
Artículo en Inglés | WPRIM | ID: wpr-129235

Documentos relacionados

  1. Pancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreas.
  2. DOG-1 positive primary acinic cell carcinoma of the lung and investigation of molecular status.
  3. Derivation of pancreatic acinar cell carcinoma cell line HS-1 as a patient-derived tumor organoid.
  4. [Rare pancreatic tumors].
  5. Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen.
  6. Pancreatic acinar cell carcinoma with pleomorphic and spindle cells: An autopsy-proven case.
  7. Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF-/MEK-inhibitor treatment-A case report and review of the literature.
  8. Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy.
  9. AGAP3: A novel BRAF fusion partner in pediatric pancreatic-type acinar cell carcinoma.
  10. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.